Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 156   

Articles published

GSK 1,371.50 0.00 (0.00%)
price chart
Why GlaxoSmithKline PLC & Hogg Robinson PLC Provide Terrific Value For Money!
With drugs giant GlaxoSmithKline (LSE: GSK) throwing the kitchen sink at developing its next generation of revenues drivers, I believe the business is in great shape to deliver stunning returns in the years ahead.
Why GlaxoSmithKline plc Might Be Worth �20!
One example of such a stock is GlaxoSmithKline (LSE: GSK). It is currently the sixth biggest company by market capitalisation in the index and its price has fallen by 9% in the last year, thereby dragging the wider FTSE 100 down.
What's Propelling GlaxoSmithKline plc (ADR) to Increase So Much? The ...
Is GlaxoSmithKline plc (ADR) (GSK) A Good Stock To Buy?  Insider Monkey (blog)
Is GlaxoSmithKline plc The Next Tesco PLC?
The thought that GlaxoSmithKline (LSE: GSK) could suffer a decline as severe as that of Tesco (LSE: TSCO) is likely to strike fear into the hearts of many income investors, including me.
GlaxoSmithKline plc 33.9% Potential Upside Indicated by Goldman Sachs
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Goldman Sachs.
GlaxoSmithKline PLC (LON:GSK) Stock “Buy” Rating Reconfirmed at Goldman ...
GlaxoSmithKline PLC (LON:GSK) Receives Buy Rating From Goldman Sachs Analysts  Risers & Fallers
GSK in China: escaping the shadow of a scandal
SHANGHAI GlaxoSmithKline Plc (GSK.L) has cut 40 percent of its sales reps in China and axed some units as it eyes a return to growth in 2016, after sales plunged during a bribery scandal that landed it with a record $490 million fine in 2014.
GlaxoSmithKline trying to escape the shadow of a bribing scandal in China  Economic Times
Are Predators Circling GlaxoSmithKline plc?
It emerged at the beginning of this month that drugs giant Pfizer had approached GlaxoSmithKline (LSE: GSK) about a possible takeover sometime during October.
Should You Invest In Dividend Delights GlaxoSmithKline plc, British American ...
Backed up by its stellar product pipeline, I believe GlaxoSmithKline (LSE: GSK) is a terrific bet for those seeking attractive income flows in the near term and beyond.
Are GlaxoSmithKline plc & AstraZeneca plc Really On The Road To Recovery?
GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) are two of the FTSE 100's most controversial companies. On one hand, the pharma giants are two of the world's premier biotechnology companies, with impressive profit margins, treatment pipelines ...
Should You Buy GlaxoSmithKline plc, Diploma PLC & Merlin Entertainments PLC?
For many investors, the most appealing thing about GlaxoSmithKline (LSE: GSK) is its dividend yield. That's because it stands at over 6%, which is over 200 basis points higher than the FTSE 100's yield of just under 4%.
GlaxoSmithKline Plc: Is The Dividend Safe?
There has been no respite for Glaxo (LSE: GSK) shares in recent weeks as investors have remained unenthused by the company's performance, with the stock falling by 6% during the month and bringing shareholders a year-to-date loss of 5.1% on their ...
GlaxoSmithKline PLC Price Target Update  Insider Trading Report